Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

Researchers receive fresh $11M to continue cracking post-TBI epilepsy

Structural brain abnormalities detected by MRI are among the risk factors the funded researchers will identify as novel biomarkers.

Academic surveyors find 56% of consumers anticipate better healthcare through AI

More than 40% of Americans are generally OK with the thought of AI reading their chest x-rays. Moreover, some 12.3% are very comfortable with the prospect.

Frontline perspectives on the CT contrast shortage: 5 notable quotes

U.S. healthcare is now a solid week into the CT contrast shortage of ’22, and common themes are emerging in adaptations at local hospitals and imaging centers.

#imagingequipment #cybersecurity #databreaches

Israel’s famously innovative healthcare system struggles to secure imaging devices

In some cases hospital staff kept no watch over outside-looking-in connections between manufacturers and scanners.

Implantable heart stimulator conditionally cleared for MRI

The FDA has OK’d the use of MR imaging for patients implanted with an autonomic heart-stimulation device as long as the device’s labeled guidelines are followed at the imaging site.

Thumbnail

VIDEO: Embracing Collaboration Among Disparate Radiology Groups

Lisa Mead, PSO executive director, Strategic Radiology, spoke at the Radiology Business Management Association (RBMA) 2022 meeting on her organization's experience collaborating with a large number of radiology groups.

Thumbnail

10 notable regulatory approvals of diagnostic devices over the past 30 days

Along with radiology-specific software and products, the list may include newly greenlit offerings for use in other settings that are increasingly important to multidisciplinary care.

Thumbnail

FDA clears spinal-tap test that could challenge PET in Alzheimer’s diagnostics

The FDA has approved a lab test for evaluating cognitively impaired adults who may be in the early stages of Alzheimer’s disease.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.